# CHEMfoot: DEBRICHEM® in Chronic Diabetic Foot Wounds

> **NCT07206862** · NA · NOT_YET_RECRUITING · sponsor: **DEBx Medical B.V.** · enrollment: 242 (estimated)

## Conditions studied

- Diabetic Foot Ulcer (DFU)
- Diabetic Foot Ulcer Treatment
- Diabetic Foot Wounds

## Interventions

- **DEVICE:** DEBRICHEM®

## Key facts

- **NCT ID:** NCT07206862
- **Lead sponsor:** DEBx Medical B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2026-12-23
- **Final completion:** 2027-02
- **Target enrollment:** 242 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07206862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07206862, "CHEMfoot: DEBRICHEM® in Chronic Diabetic Foot Wounds". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07206862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*